Co-Author
This page shows the publications co-authored by Peter Schur and Karen Costenbader.
Connection Strength
2.338
-
We need better classification and terminology for "people at high risk of or in the process of developing lupus". Arthritis Care Res (Hoboken). 2015 May; 67(5):593-6.
Score: 0.616
-
Discordance between erythrocyte sedimentation rate and C-reactive protein measurements: clinical significance. Clin Exp Rheumatol. 2007 Sep-Oct; 25(5):746-9.
Score: 0.362
-
Different indirect immunofluorescence ANA substrate performance in a diagnostic setting of patients with SLE and related disorders: retrospective review and analysis. Lupus Sci Med. 2020 11; 7(1).
Score: 0.226
-
Development of SLE among "potential SLE" patients seen in consultation: long-term follow-up. Int J Clin Pract. 2014 Dec; 68(12):1508-13.
Score: 0.144
-
Clinical manifestations and survival among adults with (SLE) according to age at diagnosis. Lupus. 2014 Jul; 23(8):778-84.
Score: 0.142
-
Association of discoid lupus erythematosus with other clinical manifestations among patients with systemic lupus erythematosus. J Am Acad Dermatol. 2013 Jul; 69(1):19-24.
Score: 0.133
-
Expression of CD44 variant isoforms CD44v3 and CD44v6 is increased on T cells from patients with systemic lupus erythematosus and is correlated with disease activity. Arthritis Rheum. 2010 May; 62(5):1431-7.
Score: 0.109
-
Development and initial validation of a self-assessed lupus organ damage instrument. Arthritis Care Res (Hoboken). 2010 Apr; 62(4):559-68.
Score: 0.108
-
Quantifying anti-cyclic citrullinated peptide titres: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis. Ann Rheum Dis. 2009 Feb; 68(2):201-8.
Score: 0.094
-
C-reactive protein, anti-C-reactive protein antibodies and clinical atherosclerosis. Vasc Med. 2008 Feb; 13(1):25-8.
Score: 0.093
-
Anti-cyclic citrullinated peptide revised criteria for the classification of rheumatoid arthritis. Ann Rheum Dis. 2008 Nov; 67(11):1557-61.
Score: 0.093
-
Barriers to a trial of atherosclerosis prevention in systemic lupus erythematosus. Arthritis Rheum. 2005 Oct 15; 53(5):718-23.
Score: 0.080
-
Elevated Anti-Citrullinated Protein Antibodies Prior to Rheumatoid Arthritis Diagnosis and Risks for Chronic Obstructive Pulmonary Disease or Asthma. Arthritis Care Res (Hoboken). 2021 04; 73(4):498-509.
Score: 0.058
-
Asthma and elevation of anti-citrullinated protein antibodies prior to the onset of rheumatoid arthritis. Arthritis Res Ther. 2019 11 21; 21(1):246.
Score: 0.053
-
Comparison of threshold cutpoints and continuous measures of anti-cyclic citrullinated peptide antibodies in predicting future rheumatoid arthritis. J Rheumatol. 2009 Apr; 36(4):706-11.
Score: 0.025
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.